Justin Albertson MS VPD Epidemiologist April 2019 Objectives Discuss measles clinical presentation Review current epidemiology Discuss appropriate lab testing Describe control measures ID: 930883
Download Presentation The PPT/PDF document "2019 Measles Update Susan Sullivan MS, R..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
2019 Measles Update
Susan Sullivan MS, RN-BC VPD Nurse ConsultantJustin Albertson MS, VPD Epidemiologist
April
2019
Slide2Objectives
Discuss measles clinical presentation Review current epidemiology
Discuss appropriate lab testing
Describe control measures
Slide3Measles
Acute viral illness
Transmitted via airborne particles or droplets
Airborne virus can remain infectious for up to 2 hours after a case occupied that space
Incubation period: 7-21 days (average 14 days
)
Infectious period: 4 days before and after rash onsetPrevented by measles-mumps-rubella vaccine (MMR)2 doses recommended (1 dose-93%; 2 doses-97% effectiveness)1st at 12-15 months of age2nd at 4-6 years of age
Slide4Clinical Picture
Prodrome
(typically lasts 2-4 days)
High fever (up to 105°), cough, coryza (runny nose), conjunctivitis
Koplick
spots
Rash (typically lasts 4-7 days)Begins a few days after prodromeMaculopapular (flat lesions and small, solid raised lesions)Begins on head and faceSpreads to trunk and extremitiesFades in order of appearance
Slide5Fifth’s Disease-parvovirusHand, Foot and Mouth Disease- coxsackie virus
Roseola-human herpesvirus 6, 7Scarlet fever-strepRocky Mountain Spotted FeverRecent antibiotic useContact dermatitis
Heat rash
Recent MMR vaccination
In sexually active adults, please rule out syphilis
Other Fever/Rash Causes
Slide6Slide7Measles Lab Testing
PCR (NC SLPH w CD Branch approval)
Throat or nasopharyngeal swab
Urine
Collect
within 3 days
of rash onsetNC SLPH now able to perform measles PCRIgM (any commercial lab)Serum specimenCollect 3 days or later after rash onsetIn vaccinated persons, there is often a blunted and/or transient production of IgMNegative
IgM in vaccinated persons suspected of having measles should not be used to rule out the
case
Viral culture (LabCorp)
Slide8Still common in Europe, Asia, the Pacific, and Africa
Travelers with measles continue to bring disease into U.S.Measles spreads in a community where groups of people are unvaccinated
Large majority of people who get measles are unvaccinated
https
://www.cdc.gov/measles/cases-outbreaks.html
Measles in the U.S.
Slide9Global View
Slide10Measles in the U.S.
https://www.cdc.gov/measles/cases-outbreaks.html
Slide11Measles in North Carolina, 2009-2018
Slide12Wake – Johnston County Measles Case: June 2018
Unvaccinated index case returned from vacation in France on 6/2/18Rash onset 6/10/18; infectious 6/6 to 6/14Exposed persons in 3 different healthcare settings on 5 separate visits from 4 other states and 15 counties
Over 300 contacts investigated; 2 family members infected
Genotype D8A; associated with outbreak strain in Europe
Slide13Health Care Settings
Presumptive immunity2 valid doses MMR
Lab evidence of immunity or previous
disease
Furlough non-immune exposed staff
Slide14The Window: Incubation period 7 to 21 days, average 14 days
6/10
Rash onset
Infectious
4
days
before & after rash onset6/66/14
6/26 - End of
incubation period
for 6/6 exposures
7/4 - End
of
incubation period
for 6/14 exposures
PEP-MMR within 3 days of exposure;
IG within 6 days of exposure
Slide15§ 130A-145. Quarantine and isolation authority
(a) The State Health Director and a local health director are empowered to exercise quarantine and isolation authority. Quarantine and isolation authority shall be exercised only
when and so long as the public health is endangered, all other reasonable means for correcting the problem have been exhausted, and no less restrictive alternative exists.
(b) A person convicted under this section for violation of G.S. 130A-145 shall not be sentenced under Article 81B of Chapter 15A of the General Statutes but shall instead be sentenced to a term of imprisonment of no more than two years…
Slide161. Immune Status
Shot record, disease history?Vaccine effectivenessWaning immunity?2. Clinical Presentation
Onset date of each symptom
Classic or modified presentation?
Lab results
3. Epidemiology
What is incubation period? Infectious period?Demographics, travel, employment, activities, school, congregate settings 163 Basic VPD Questions: ICE
Slide17ScreenImmune status
Clinical informationEpi, activities, travel, exposure historyIsolateAirborne precautions for measles2 hour timeframe even after patient leaves
Call public health immediately
Assure control measures are initiated
Arrange for appropriate testing
Begin contact investigation
3 Basic Response Steps for Healthcare Settings
Slide18Identify infection; manage case
Define population at riskManage non-immune exposed personsVaccinate?
Exclude?
4. Obtain appropriate clinical specimens
5. Maintain surveillance
18
5 VPD Control Strategies for Public Health
Educate
!
Slide19Most clinicians have never seen a true case of measles
Immune status, clinical presentation and epi (travel history) need to be assessed for every patient presenting in an urgent care settingMost adults do not have ready access to their shot recordsUnvaccinated returning travelers continue to be a source of measles spread in the U.S.
Lessons learned